[ Back to EurekAlert! ]

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles Health Sciences

Impact of HDL Peptide 4F on Pulmonary Hypertension

Caption: This images shows the differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent (left) treated with the HDL peptide. Note the very narrowed lung artery, and thick walls and larger chamber of the right heart in the diseased animal and improvements with 4F peptide treatment.

Credit: UCLA

Usage Restrictions: None

Related news release: Protein in 'good cholesterol' may be a key to treating pulmonary hypertension


[ Back to EurekAlert! ]